Caprock Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $758K | Sell |
1,195
-452
| -27% | -$287K | 0.02% | 559 |
|
|
2024
Q4 | $1.17M | Buy |
1,647
+351
| +27% | +$250K | 0.04% | 383 |
|
|
2024
Q3 | $1.36M | Sell |
1,296
-90
| -6% | -$94.6K | 0.05% | 320 |
|
|
2024
Q2 | $1.46M | Buy |
1,386
+521
| +60% | +$548K | 0.06% | 285 |
|
|
2024
Q1 | $833K | Buy |
865
+68
| +9% | +$65.4K | 0.05% | 286 |
|
|
2023
Q4 | $700K | Sell |
797
-153
| -16% | -$134K | 0.04% | 305 |
|
|
2023
Q3 | $782K | Sell |
950
-148
| -13% | -$122K | 0.06% | 259 |
|
|
2023
Q2 | $789K | Buy |
1,098
+188
| +21% | +$135K | 0.06% | 262 |
|
|
2023
Q1 | $748K | Buy |
910
+240
| +36% | +$197K | 0.06% | 255 |
|
|
2022
Q4 | $483K | Buy |
670
+132
| +25% | +$95.2K | 0.05% | 290 |
|
|
2022
Q3 | $371K | Buy |
538
+66
| +14% | +$45.5K | 0.04% | 355 |
|
|
2022
Q2 | $279K | Sell |
472
-5
| -1% | -$2.96K | 0.03% | 403 |
|
|
2022
Q1 | $333K | Buy |
477
+40
| +9% | +$27.9K | 0.03% | 385 |
|
|
2021
Q4 | $276K | Sell |
437
-13
| -3% | -$8.21K | 0.02% | 457 |
|
|
2021
Q3 | $272K | Buy |
450
+44
| +11% | +$26.6K | 0.02% | 411 |
|
|
2021
Q2 | $227K | Buy |
+406
| New | +$227K | 0.02% | 467 |
|
|
2021
Q1 | – | Sell |
-426
| Closed | -$206K | – | 520 |
|
|
2020
Q4 | $206K | Sell |
426
-146
| -26% | -$70.6K | 0.02% | 440 |
|
|
2020
Q3 | $320K | Buy |
572
+156
| +38% | +$87.3K | 0.04% | 280 |
|
|
2020
Q2 | $259K | Buy |
+416
| New | +$259K | 0.04% | 314 |
|